We are live on ! Find out more
GC

Guggenheim Capital Portfolio holdings

AUM $12.9B
1-Year Est. Return 27.3%
This Fund
S&P 500
This Quarter Est. Return
+8.99%
1 Year Est. Return
+27.3%
3 Year Est. Return
+83.37%
5 Year Est. Return
+104.66%
10 Year Est. Return
+386.48%
AUM
$19.2B
AUM Growth
+$2.52B
Cap. Flow
+$1.25B
Cap. Flow %
6.54%
Top 10 Hldgs %
17.34%
Holding
2,313
New
197
Increased
1,021
Reduced
855
Closed
212

Sector Composition

Rank Sector Weight
1 Technology 20.39%
2 Financials 15.67%
3 Healthcare 9.34%
4 Consumer Discretionary 9.15%
5 Real Estate 6.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UHS icon
826
Universal Health Services
UHS
$10.5B
$3.5M 0.02%
26,992
+8,712
+48% +$1.12M
KGC icon
827
Kinross Gold
KGC
$32.8B
$3.5M 0.02%
601,502
-192,752
-24% -$1.15M
RIO icon
828
Rio Tinto
RIO
$164B
$3.47M 0.02%
51,773
-4,210
-8% -$273K
AM icon
829
Antero Midstream
AM
$10.1B
$3.46M 0.02%
357,883
-2,830
-0.8% -$29.3K
HI
830
DELISTED
Hillenbrand
HI
$3.46M 0.02%
66,549
+16,313
+32% +$779K
GHY
831
PGIM Global High Yield Fund
GHY
$483M
$3.42M 0.02%
226,357
+25,302
+13% +$388K
CUZ icon
832
Cousins Properties
CUZ
$4.88B
$3.41M 0.02%
84,605
+51,017
+152% +$2.01M
MDU icon
833
MDU Resources
MDU
$4.32B
$3.38M 0.02%
288,514
-83,817
-23% -$945K
KL
834
DELISTED
Kirkland Lake Gold Ltd Ordinary
KL
$3.37M 0.02%
80,280
-46,457
-37% -$1.96M
MAS icon
835
Masco
MAS
$15.3B
$3.37M 0.02%
47,945
-41,185
-46% -$2.66M
ARWR icon
836
Arrowhead Research
ARWR
$12.4B
$3.36M 0.02%
50,729
-1,644
-3% -$113K
BHVN
837
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$3.36M 0.02%
24,398
+5,477
+29% +$696K
CNP icon
838
CenterPoint Energy
CNP
$26.8B
$3.36M 0.02%
120,271
+5,347
+5% +$143K
MMU
839
Western Asset Managed Municipals Fund
MMU
$554M
$3.35M 0.02%
256,208
+71,165
+38% +$937K
PHT
840
DELISTED
Pioneer High Income Fund
PHT
$3.35M 0.02%
344,920
+12,390
+4% +$122K
RGLD icon
841
Royal Gold
RGLD
$19.5B
$3.33M 0.02%
31,681
-13,188
-29% -$1.33M
USA icon
842
Liberty All-Star Equity Fund
USA
$1.85B
$3.33M 0.02%
397,085
-43,778
-10% -$370K
SEE
843
DELISTED
Sealed Air
SEE
$3.32M 0.02%
49,189
+524
+1% +$32.6K
NMAI icon
844
Nuveen Multi-Asset Income Fund
NMAI
$485M
$3.32M 0.02%
+177,869
New +$3.23M
BKN
845
DELISTED
BlackRock Investment Quality Municipal Trust
BKN
$3.31M 0.02%
191,075
-80,923
-30% -$1.4M
IJH icon
846
iShares Core S&P Mid-Cap ETF
IJH
$127B
$3.31M 0.02%
58,500
+7,765
+15% +$432K
LAKE icon
847
Lakeland Industries
LAKE
$119M
$3.3M 0.02%
152,155
CLF icon
848
Cleveland-Cliffs
CLF
$6.99B
$3.3M 0.02%
151,572
+67,324
+80% +$1.45M
HEQ
849
John Hancock Hedged Equity & Income Fund
HEQ
$140M
$3.29M 0.02%
253,496
+48,378
+24% +$622K
NLY icon
850
Annaly Capital Management
NLY
$17.4B
$3.29M 0.02%
105,048
+28,038
+36% +$942K

Similar funds

Guggenheim Capital's Q4 2021 Portfolio in Review

As of Q4 2021, Guggenheim Capital held 2,313 positions worth $19.2B, up 15% from $16.7B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Guggenheim Capital deployed $1.25B of net new capital in Q4 2021, opening 197 new positions and adding to 1,021 existing holdings. Its largest new stake was AfterNext HealthTech Acquisition Corp: 3,725,000 shares worth $36.3M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Tesla, an estimated $28.7M trimmed.

  • Guggenheim Capital's largest Q4 2021 buy was AfterNext HealthTech Acquisition Corp: 3,725,000 shares worth $36.3M.
  • Guggenheim Capital added most to FIGS in Q4 2021, an estimated $173M increase.
  • Guggenheim Capital's biggest Q4 2021 reduction was Tesla, cutting an estimated $28.7M.
  • Guggenheim Capital fully exited AfterNext HealthTech Acquisition Corp Units in Q4 2021, selling an estimated $37.1M.
  • Guggenheim Capital's ten largest holdings make up 17% of its $19.2B portfolio in Q4 2021.
  • Guggenheim Capital opened 197 new positions and closed 212 in Q4 2021.
  • Guggenheim Capital's portfolio value rose 15% quarter-over-quarter to $19.2B.

Based on Guggenheim Capital's 13F filing for Q4 2021, filed 14 Feb 2022.